Way back in August OBJ released an announcement that stated the company had received notification from its patent attorney that “the patent application, protecting the Company’s powered electromagnetic fields drug delivery technology for the USA, had proceeded to allowance”.
This announcement then went on to say that subject to OBJ paying the applicable fees the full patent would be granted within 3 months.
A short while later I posted an article entitled “Granting of Patent on the Horizon” this provided some information on research conducted by a poster on Hotcopper and included a link showing that our patent had been awarded.
So I don’t know why there was such a time delay between that information being released on a public website and today’s announcement, but we finally received confirmation that OBJ has received the Dermaportation Patent.
The announcement also contained this paragraph which I thought was worth reviewing. I have highlighted the important sections in bold.
“The granting of the patent enhances the potential commercial value of the Company’s powered Dermaportation technology as it allows the Company to offer various market licensing options to potential partners in key market sectors.
The Company has identified several commercial opportunities for Dermaportation and has introduced the technology to potential partners”
In my opinion this underscores the wide variety of applications and partnering opportunities available to OBJ and just reinforces the potential of this technology in my mind. As I have previously commented on some the patent was granted any risk to our partners having their products copied or stolen has now been significantly reduced. This should open the way for more concrete agreements to be forthcoming.
Disclaimer: As always please do your own research and consult a licence financial advisor before making any investment decision.
No comments:
Post a Comment